The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast.

Sneha PanditharDaniel GalkeAhone AkumeArtem BelyakovDominick LomonacoAmirah A GuerraJay ParkOlivia ReffKideok Jin

Published in: Molecular biology reports (2024)

Taken together, our study implicates CXCL1 as a critical role in ERBC growth and metastasis via crosstalk with fibroblast and cotargeting CXCR1/2 and CDK4/6 could potentially overcome endocrine resistant breast cancer.

Keyphrases

cell cycle
breast cancer risk
cell proliferation
young adults
cell migration